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Abstract
Catheter ablation (CA) is a potentially curative ther-
apy for paroxysmal atrial fibrillation, however up to 50%
of patients may require a repeat procedure to achieve the
best results. While this may be due to insufficient radiofre-
quency (RF) energy delivery to achieve transmural, con-
tiguous ablation lesions (TAL), excessive RF application
may result in extracardiac injury and complications. We
aim to evaluate optimal RFCA temperature settings for
variable atrial tissue depth and blood flow conditions.
Heat spread in atrial tissue and blood was simulated
using the Pennes bioheat equation with an additional con-
vective term in the blood. The minimum catheter contact
time required for TAL formation increased with increasing
either atrial wall thickness (AWT) or laminar flow veloc-
ity (LFV). Thus, during ablation of atrial tissue regions
with AWT of 1 and 5.5 mm and LFV of 0.1 m/s, TALs were
formed in 12 and 153 s, respectively. When LFV was in-
creased to 1.2 m/s, the TAL formation time increased to 21
and 174 s. The maximum temperature in the blood volume
stayed below the coagulation risk threshold of 70°C for all
AWT values with LFVs over 0.6 m/s, but raised above the
threshold for LFV 6 0.6 m/s and AWT > 1.5 mm.
This study demonstrates the potential for optimizing
RFCA settings according to atrial tissue depth and flow,
which may improve the efficacy of RFCA therapy.
1. Introduction
Atrial fibrillation (AF) is the most common cardiac ar-
rhythmia, affecting over 30 million people worldwide [1].
It is characterised by irregular, rapid electrical activations
of the atria and carries a high risk of heart failure and
stroke. Radiofrequency catheter ablation (RFCA) is gradu-
ally supplanting antiarrhythmic drug therapy as a front-line
treatment for AF termination. This procedure delivers RF
energy via a catheter to produce produce electrically inert,
transmural lesions in the myocardium to isolate or remove
areas contributing to the generation or maintenance of the
activity sustaining AF (e.g., drivers near the pulmonary
veins, PVs) [2]. In the absence of new electrical drivers,
reoccurrence of AF may be due to gaps between lesions or
a lack of transmurality, which both prevent the complete
isolation of the drivers [3].
However, RFCA procedures are not always effective.
The success rates for single-procedure PV isolations in
paroxysmal AF patients are only 38-70% [1]. In persis-
tent AF, PV isolation alone is not sufficient and further ar-
eas of the atrial wall are targeted. Moreover, in 4.5% of
patients RFCA procedures can result in major complica-
tions[4]. In-vitro studies also suggest that in regions with
high blood flow rate and convective cooling, e.g., above
the mitral valve, more power must be supplied to achieve
transmural lesions, resulting in higher localised tempera-
ture, overheating atrial tissue and producing larger lesions
[5,6]. This excessive ablation can cause permanent loss of
contractility outside of target areas and heart failure [7].
As blood flow rates vary considerably inside the atria,
the lesion size is hard to predict. Additionally, high inter-
and intra- patient variations in atrial wall thickness (AWT)
[8] presents a major issue when creating the transmural le-
sions required for effective RFCA treatments. Knowledge
of both AWT and blood flow rates could provide clinicians
with useful information to optimise the ablation procedure
– by using the minimal amount of RF energy and catheter
contact time to achieve lesion transmurality. Furthermore,
such knowledge could also reduce the risk of complica-
tions. For example, PV stenosis can be avoided by min-
imising catheter contact time at target areas to ensure tem-
peratures stay below risk levels [9].
This study aims to apply computational modelling [10,
11] to simulate RFCA in realistic atrial blood flow and wall
thickness settings. This will provide novel information on
the minimal catheter contact time required to fully form
transmural ablation lesions (TAL) – while also assessing
the risks of complications – for specific flow and AWT. The
model predictions could potentially be used to improve the
efficacy and safety of RFCA procedures in the clinic.
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2. Methods
2.1. Thermal model with convection
To simulate the temperature distributions in atrial tissue
and blood the Pennes bioheat equation with an additional
convective term in the blood was used [11]:
c
∂T
∂t
= D∇2T +Qcath − ~v · ∇T (1)
where
D = k/ρc
Qcath = ~E · ~J = σ(∇V )2
~E = ∇V
~J = σ∇V
and the voltage is determined from the Laplace’s equation:
∇2V = 0
The variables in the equations above are as follows:
c heat capacity of the myocardium (J/(kg·K))
T temperature of the blood or myocardium (K)
D thermal diffusivity (m2/s)
Qcath heat applied by the catheter (W/m3)
~v blood velocity (m/s)
k thermal conductivity (W/(m·K))
ρ density (kg/m3)
σ electric conductivity (S/m)
~E electrical field intensity (V/m)
~J current density (A/m2)
Heat loss due to perfusion in the myocardium was ne-
glected as nominal relative to the heat applied during ab-
lation. The Arrhenius method was used to evaluate tissue
thermal injury leading to the TAL formation:
Ω(t) =
∫ t
0
A · e−∆ERT dt = ln
[
c(0)
c(t)
]
(2)
where Ω(t) is interpreted as the logarithmic ratio of un-
damaged tissue at time 0 and ratio of damaged tissue at
time t; A is the rate factor measuring collision (s−1); ∆E
is the energy barrier the tissue must exceed to be denatured
(J/mol) and R is universal gas constant (8.3134 J/mol·K).
If Ω(t) = 1 this indicates 63 % probability of irreversible
tissue damage and Ω(t) > 4.3 indicates 99 % probability.
Equations were solved using the finite difference
method on a uniform 3D rectangular domain measuring
50× 100× 50 voxels with a spatial step of 0.25 mm. The
tissue slab measured 50 × 100 × n/0.25, where n rep-
resented slab thickness in mm, and the remainder of the
domain represented blood. The temporal step was set at 5
ms. Throughout the domain an initial temperature was set
at 37 °C (310.15 K) and a uniform potential set at 0 V.
Values for the constants were determined from literature
used for both blood [12] and myocardium (see Table 1).
Blood was assumed to have a haematocrit of 40 %.
Table 1. Constants used in the model
ρ c k
kg·m−3 J/kg·K W/m·K
Tissue 1,200 3,200 0.55
Blood 1,060 3,947 0.57
σ A ∆E
S/m s−1 J/mol
Tissue 0.222 1.28×1022 145,000
2.2. Ablation simulation settings
To explore the relationship between atrial wall depth,
blood flow velocity and TAL formation, a series of atrial
tissue slabs with blood volume (see Figure 1) were created
with AWT defined between 1.0-5.5 mm [8] in steps of 0.5
mm. For each slab, a series of simulations was performed
with a uniform laminar flow velocity (LFV) specified in
the blood and varied between 0.0-1.2 m/s [13] in steps of
0.2 m/s. In each simulation, an initial voltage of 10 V was
applied to the catheter positioned in the bloodstream on
the endocardial surface of the tissue. The simulation con-
tinued until some point of the myocardium on the opposite,
epicardial surface reached a value of Ω ≥ 1, indicating the
creation of a transmural lesion through the atrial wall.
3. Results
Figure 1 illustrates ablation simulations in 3D atrial
slabs with varying AWT under the blood with varying
LFV, with the catheter tip positioned at the tissue-blood
interface. Both temperature (left panels) and the Ω-value
(right panels) representing tissue damage are mapped, and
regions where Ω ≥ 1 (corresponding to scar tissue form-
ing the lesion) are highlighted. The extremes of the varying
LFV are illustrated – a stagnant 0.0 m/s flow to the highest
simulated velocity of 1.2 m/s in steps of 0.2 m/s – for three
representative AWT values, 1.0 mm, 3.5 mm and 5.0 mm.
Figure 1 shows that blood flow had a significant impact
on the shape of ablation lesions. At zero velocity, the le-
sion formed in a hemisphere like shape evenly around the
region in contact with the catheter tip. This was due to the
even spreading of heat around the ablation contact area.
When exposed to the flow, the temperature distribution
changed, with the higher temperatures being downstream
of the catheter tip. This change in the temperature distri-
bution causes the lesion to form as a semi-ellipsoid with
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Figure 1. Temperature distribution in atrial tissue and blood: The figure shows temperature distributions in transmural
cross sections through 3D atrial slabs under the blood volume (left panels), and the respective cross sections and top down
projections of the Ω-value (right panels) in the tissue for AWT of 1.0 mm (top), 3.5 mm (middle) and 5.0 mm (bottom)
and LBF of 0.0 m/s (left) and 1.2 m/s (right). The position of the catheter tip (red) for each simulation is shown. The
regions where Ω ≥ 1 indicating a 63 % chance of irreversible tissue damage are highlighted (black). The regions where
temperature was recorded being ≥ 70 °C also are highlighted (white) due to the additional risk of blood clot formation.
the long axis in the direction of flow. The point which first
reaches Ω ≥ 1 on the opposing side of the atrial wall also
changes, shifting from being directly opposite the mid-
point of the catheter tip to being at a point downstream.
Figure 1 also shows that higher LFV tended to be as-
sociated with lower blood temperatures, and blood was
observed to heat to higher temperatures when LFV was
low. The figure highlights regions above 70 °C, which have
been associated with a higher likelihood of blood clot for-
mation during the ablation process [14].
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Figure 2. Effect of AWT and LFV on the time to full
TAL formation: This was measured as the time when Ω
reached a value ≥ 1 on the epicadial side of the atrial wall
– oppose the catheter tip applied on the endocardium. Here
and below, each line represents a different blood velocity.
Figure 2 shows the time to TAL formation (full lesion
extending from endocardium to epicardium) against AWT
for each value of velocity from 0.0 m/s to 1.2 m/s. The fig-
ure suggests that higher flow velocities and thicker atrial
wall corresponded to longer times to TAL formation, with
the the formation time showing a stronger dependence on
the AWT. Note that percentage change in the TAL forma-
tion time was similar for AWT values of 1 and 5 mm: in
both cases, the lesion took 23% longer to form when LFV
was 1.2 m/s rather than zero. The greatest change was seen
for AWT of 2.5 mm, where the difference in TAL forma-
tion time was 50.38% between LFV of 0.0 and 1.2 m/s.
This result suggests that at such intermediate AWT values
blood flow has a greater influence on lesion formation.
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Figure 3. Effect of AWT and LFV on the lesion length:
The figure shows length of the long axis of the lesion. Vox-
els along this axis with Ω ≥ 1 were those sampled.
Figure 3 shows the effect varying AWT and blood ve-
locity had on the length of the resulting lesion, with higher
velocities associated with longer lesions.
Figure 4 shows the effect varying AWT and LFV had on
the blood maximum temperature. The figure suggests that
the peak temperatures are observed in low blood velocities
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Figure 4. Effect of AWT and LFV on the maximum
blood temperature: The figure shows the maximum tem-
perature recorded in the blood for each simulation.
and higher AWT cases. Interestingly, at 1 mm AWT the
highest blood temperatures are recorded at an intermediate
LFV of 0.6 m/s. The reason for the peak temperature not
being observed at 0.0 m/s, as seen for greater AWT, is due
to the faster speed of the TAL formation for lower AWT
and LFV which does not allow the blood time to heat up.
4. Discussion
We developed a novel computational approach to eval-
uate RFCA settings for realistic atrial tissue depth and
flow conditions. For the catheter voltage of 10 V (corre-
sponding to RF power of 70 W), the TAL formation time
required for achieving effective TALs increased quasi-
linearly with both increasing AWT and LFV, with a faster
rate of increase for AWT. Both the TAL formation time
(Figure 2) and length (Figure 3) can change 10-fold be-
tween the condition of low and high AWT and LFV. How-
ever, these minimal TAL formation times were generally
shorter than catheter contact times in common use. Inter-
estingly, the blood flow had a greater influence on the TAL
formation at intermediate AWT values of 2.5 mm, which
are average values seen the atrial walls [8]. Risks of the
heat-induced blood coagulation due to temperature ≥ 70
°C [14] also varied with AWT and LFV (Figure 4).
Limitations of the study include the consideration of
only simple 3D slab geometries and laminar flow condi-
tions. Future studies will focus on combining the current
approach with anatomically detailed 3D atrial models [10]
and accurate 3D blood flow simulations [15].
In summary, this study demonstrates the potential for
optimizing RFCA settings according to variable atrial tis-
sue depth and flow conditions, which can help improve the
safety and efficacy of RFCA therapy in the future.
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